
    
      Patients will be screened for eligibility to determine if they meet all inclusion/exclusion
      criteria. The screening period will be up to 4 weeks. Patient's baseline LIC will be
      determined non-invasively by means of MRI R2 analysis. In addition, blood and urine samples
      will be taken for the determination of baseline safety data.
    
  